• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, March 28, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

India Pesticides files IPO papers with Sebi, plans to launch Rs 800-crore public issue

by The Outlooker Web Desk
February 10, 2021
in Business
0
India Pesticides files IPO papers with Sebi, plans to launch Rs 800-crore public issue
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

India Pesticides in DRHP said that if the pre-IPO placement takes place then the amount raised from the pre-IPO placement will be reduced from the fresh issue. Image: Reuters

Agrochemical technicals company India Pesticides Ltd has filed preliminary papers with capital markets regulator Sebi. The Uttar Pradesh-based company looks to raise Rs 800 crore through an initial public offering which comprises fresh issue of shares worth Rs 100 crore and an offer of sale (OFS) of Rs 281.4 crore by promoter Anand Swarup Agarwal and Rs 418.6 crore by selling shareholders, according to draft red herring prospectus. The equity shares are proposed to be listed on BSE and NSE.

The company and selling shareholders in consultation with book running lead managers may consider a further pre-IPO placement issue of Rs 75 crore. The company in DRHP said that if the pre-IPO placement takes place then the amount raised from the pre-IPO placement will be reduced from the fresh issue. The book running lead managers to the issue are Axis Capital Ltd and JM Financial Ltd, while the registrar to the offer is KFin Technologies Private Ltd. The company is the sole Indian manufacturer and among top five manufacturers globally for several Technicals, such as, Folpet and Thiocarbamate Herbicide, used to make herbicide, insecticide and fungicides that control fungal growth across a variety of crops.

India Pesticides listed peers include Dhanuka Agritech Ltd, Bharat Rasayan Ltd, UPL Ltd, Rallis India Ltd, PI Industries Ltd, Sumitomo Chemical India Ltd and Atul Ltd, have respective P/E ratios at 26.08. 27.46, 24.15, 30.41, 66.56, 76.67 and 29.26. The company in DRHP stated that the proceeds of the OFS will be received by the selling shareholders. The Company will not receive any proceeds from the OFS. As for the fresh issue, India Pesticides has planned to utilise the net proceeds for funding working capital requirement of the company, and general corporate purposes. India Pesticides currently operates from two manufacturing facilities located at Dewa Road, Lucknow and Sandila, Hardoi in Uttar Pradesh, with an aggregate capacity of 19,500 MT for technicals and 6,500 MT for the formulations vertical.

It also manufactures active pharmaceutical ingredients (APIs) and has obtained a license for manufacturing two drugs for sale at Dewa Road from the Drug Licensing and Controlling Authority. For the six months ended September 30, 2020, India Pesticides posted a profit of Rs 72.3 crore while for the financial year 2020, it reported a profit of Rs 70.58 crore.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post

Uber's Turbulent Week: Kalanick Out, New Twist In Google Lawsuit

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot
National

Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot

March 28, 2023
18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources
National

18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources

March 28, 2023
UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case
National

UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case

March 28, 2023
Bureaucrat Swims From Gateway Of India To Elephanta Caves In Less Than 6 Hours
National

Bureaucrat Swims From Gateway Of India To Elephanta Caves In Less Than 6 Hours

March 28, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Gandhi Family Is Congress Pivot, Keeps Party United: Ashok Gehlot
  • 18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources
  • UP Gangster Atiq Ahmed Found Guilty In Kidnapping Case

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.